Stock PFIZ34 PFIZER INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Pfizer Inc. Sao Paulo

Equities

PFIZ34

BRPFIZBDR006

Market Closed - Sao Paulo
Other stock markets
 21:05:00 31/05/2024 BST 		5-day change 1st Jan Change
37.44 BRL +10.92% Intraday chart for Pfizer Inc. +0.54% +7.96%
06-01 Delaware judge lets more than 70,000 Zantac lawsuits go forward RE
05-31 Sector Update: Health Care Stocks Higher Late Afternoon MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Delaware judge lets more than 70,000 Zantac lawsuits go forward
Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
Sector Update: Health Care Stocks Higher Late Afternoon
Sector Update: Health Care Stocks Advance Friday Afternoon
Sector Update: Health Care
Pfizer Reports Encouraging Long-Term Trial Results of Advanced Lung Cancer Drug
US FDA approves Moderna's RSV vaccine, its second marketed product
Patents, Policies And Privacy: The Highs And Lows Of Technology In IP
Pfizer Says Lorbrena Shows Positive Long-Term Results in Advanced Lung Cancer Patients
Pfizer Study Shows Lorbrena Reduces Chances of Lung Cancer Getting Worse
Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
Pfizer Inc.'s LORBRENA CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
Pfizer : Receives Positive CHMP Opinion for its One-Time Gene Therapy for Adults with Hemophilia B
Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns
Pfizer : Showcases New Data Across its Broadened Oncology Portfolio at ASCO Annual Meeting
BioNTech gets $145 mln funding for African vaccine plants
BioNTech wins up to $145 mln in CEPI support for African mRNA vaccine plants
Pfizer : Reiterates Commitment to Pandemic Preparedness
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PFE Stock
  4. PFIZ34 Stock
  5. News Pfizer Inc.
  6. Other languages